Search results for: 'vaccine 2025 2025 deal trends players and financial'
- Did you mean
- vaccine 2004 2004 deaf terns plagens and financial
- Related search terms
- vaccine 2023 2023 deal trend players and financi
- vaccine 2024 2020 deal trends players and financi
- vaccine 2023 2023 deal trend players and financial
- vaccine 221b 221b deal trend plagens and financial
- vaccine 2004 221b deal trend plagens and financial
-
Gene Editing Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025July 2025$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Artificial Intelligence (AI) Collaboration and Licensing Deals in Pharma, Biotech and Diagnostics 2019-2025November 2025$3,995.00Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Big Pharma Partnering Terms and Agreements 2020-2025July 2025$5,995.00Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More -
Antibody Collaboration and Licensing Deals 2019-2026April 2026$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Collaboration Deals in Biotechnology 2020-2026March 2026$4,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Licensing Deals in Biotechnology 2020-2026March 2026$4,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2026March 2026$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026March 2026$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More
